BDNF +/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain

GLIA

Volumn 58, Issue 7, 2010, Pages 848-856

  Vondran, Melissa W ^a,b   Clinton Luke, Patricia ^a   Honeywell, Jean Z ^a,b   Dreyfus, Cheryl F ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Glia; Glial development; Growth factors; MBP; Neurotrophins; NG2

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DNA; GROWTH FACTOR; MYELIN PROTEIN; NEUROTROPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; FOREBRAIN; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIGENS; BASAL NUCLEUS OF MEYNERT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELL LINEAGE; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELIN PROTEINS; OLIGODENDROGLIA; PROTEOGLYCANS; RECEPTOR, TRKB; STEM CELLS;

EID: 77952562399     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20969     Document Type: Article

References (60)

1. Abercrombie M. 1946. Estimation of nuclear population from microtome sections. Anat Rec 94:239-247.
2. Alderson RF, Alterman AL, Barde YA, Lindsay RM. 1990. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 5:297-306.
3. Atanasoski S, Scherer SS, Sirkowski E, Leone D, Garratt AN, Birchmeier C, Suter U. 2006. ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury. J Neurosci 26:2124-2131.
4. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. 2002. Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209-245.
5. Azoulay D, Vachapova V, Shihman B, Miler A, Karni A. 2005. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate. J Neuroimmunol 167(1/2):215-218.
6. Baracskay KL, Kidd GJ, Miller RH, Trapp BD. 2007. NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells. Glia 55:1001-1010.
7. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
8. Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367:371-375.
9. Bartoletti A, Cancedda L, Reid SW, Tessarollo L, Porciatti V, Pizzorusso T, Maffei L. 2002. Heterozygous knock-out mice for brain-derived neurotrophic factor show a pathway-specific impairment of long-term potentiation but normal critical period for monocular deprivation. J Neurosci 22:10072-10077. (Pubitemid 35416844)
10. Bartzokis G. 2004. Age-related myelin breakdown: A developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25:5-18; author reply 49-62.
11. Benveniste EN, Merrill JE. 1986. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321:610-613.
12. Bjartmar C, Hildebrand C, Loinder K. 1994. Morphological heterogeneity of rat oligodendrocytes: Electron microscopic studies on serial sections. Glia 11:235-244. (Pubitemid 2111099)
13. Bobholz JA, Rao SM. 2003. Cognitive dysfunction in multiple sclerosis: A review of recent developments. Curr Opin Neurol 16:283-288.
14. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD. 1998. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20:869-882.
15. Casanova MF, Walker LC, Whitehouse PJ, Price DL. 1985. Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 18:310-313.
16. Cellerino A, Carroll P, Thoenen H, Barde YA. 1997. Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brainderived neurotrophic factor. Mol Cell Neurosci 9(5/6):397-408.
17. Chourbaji S, Hellweg R, Brandis D, Zorner B, Zacher C, Lang UE, Henn FA, Hortnagl H, Gass P. 2004. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 121:28-36.
18. Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA. 1996. Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16:6433-6442. (Pubitemid 26337367)
19. Del Rio-Hortega P. 1928. Tercera aportacion al conocimiento morfologico e interpretacion funcional de la oligodendroglia. Mem Real Soc Esp Hist Nat 14:40-122.
20. Djalali S, Höltje M, Grosse G, Rothe T, Stroh T, Grosse J, Deng DR, Hellweg R, Grantyn R, Hörtnagl H, Ahnert-Hilger G. 2005. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem 92:616-627.
21. Du Y, Fischer TZ, Clinton-Luke P, Lercher LD, Dreyfus CF. 2006a. Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes. Mol Cell Neurosci 31:366-375.
22. Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF. 2003. Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25(2-4):116-126.
23. Du Y, Lercher LD, Zhou R, Dreyfus CF. 2006b. Mitogen-activated protein kinase pathway mediates effects of brain-derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes. J Neurosci Res 84:1692-1702.
24. Elkabes S, DiCicco-Bloom EM, Black IB. 1996. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 16:2508-2521. (Pubitemid 26122673)
25. Ernfors P, Lee KF, Jaenisch R. 1994. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368:147-150.
26. Fontaine B, Seilhean D, Tourbah A, Daumas-Duport C, Duyckaerts C, Benoit N, Devaux B, Hauw JJ, Rancurel G, Lyon-Caen O. 1994. Dementia in two histologically confirmed cases of multiple sclerosis: One case with isolated dementia and one case associated with psychiatric symptoms. J Neurol Neurosurg Psychiatry 57:353-359. (Pubitemid 24083422)
27. Friedman WJ, Ibanez CF, Hallbook F, Persson H, Cain LD, Dreyfus CF, Black IB. 1993. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol 119:72-78.
28. Grosse G, Djalali S, Deng DR, Höltje M, Hinz B, Schwartzkopff K, Cygon M, Rothe T, Stroh T, Hellweg R, Ahnert-Hilger G, Hörtnag H. 2005. Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain. Brain Res Dev Brain Res 156:111-126.
29. Hartman BK, Agrawal HC, Agrawal D, Kalmbach S. 1982. Development and maturation of central nervous system myelin: Comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes. Proc Natl Acad Sci USA 79:4217-4220.
30. Heinrich M, Gorath M, Richter-Landsberg C. 1999. Neurotrophin-3 (NT-3) modulates early differentiation of oligodendrocytes in rat brain cortical cultures. Glia 28:244-255.
31. Huang EJ, Reichardt LF. 2001. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
32. Jones KR, Farinas I, Backus C, Reichardt LF. 1994. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76:989-999.
33. Kermani P, Hempstead B. 2007. Brain-derived neurotrophic factor: A newly described mediator of angiogenesis. Trends Cardiovasc Med 17:140-143.
34. Kitada M, Rowitch DH. 2006. Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 54:35-46.
35. Klein R, Parada LF, Coulier F, Barbacid M. 1989. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J 8:3701-3709. (Pubitemid 20016049)
36. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C. 2008. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 258:124-128.
37. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L. 1999. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:15239-15244.
38. Mann DM, Yates PO, Marcyniuk B. 1984. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10:185-207. (Pubitemid 14121330)
39. Mason JL, Goldman JE. 2002. A2B5+ and O4+ Cycling progenitors in the adult forebrain white matter respond differentially to PDGF-AA, FGF-2, and IGF-1. Mol Cell Neurosci 20:30-42.
40. McKinnon RD, Matsui T, Aranda M, Dubois-Dalcq M. 1991. A role for fibroblast growth factor in oligodendrocyte development. Ann N Y Acad Sci 638:378-386.
41. McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N. 1993. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann N Y Acad Sci 692:321-334. (Pubitemid 23299558)
42. Medina DL, Sciarretta C, Calella AM, Von Bohlen Und Halbach O, Unsicker K, Minichiello L. 2004. TrkB regulates neocortex formation through the Shc/PLCgamma-mediated control of neuronal migration. EMBO J 23:3803-3814.
43. Nishiyama A. 2007. Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist 13:62-76.
44. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB. 1996. Colocalization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43:299-314. (Pubitemid 26054018)
45. Peyser JM, Rao SM, LaRocca NG, Kaplan E. 1990. Guidelines for neuropsychological research in multiple sclerosis. Arch Neurol 47:94-97. (Pubitemid 20024163)
46. Power J, Mayer-Proschel M, Smith J, Noble M. 2002. Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. Dev Biol 245:362-375.
47. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. 1988. Platelet- derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562-565.
48. Rao SM, Leo GJ, Bernardin L, Unverzagt F. 1991. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685-691.
49. Robinson S, Miller R. 1996. Environmental enhancement of growth factor-mediated oligodendrocyte precursor proliferation. Mol Cell Neurosci 8:38-52.
50. Scarisbrick IA, Asakura K, Rodriguez M. 2000. Neurotrophin-4/5 promotes proliferation of oligodendrocyte-type-2 astrocytes (O-2A). Brain Res Dev Brain Res 123:87-90.
51. Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP. 2007. Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial. J Neurol Sci 255(1/2):57-63.
52. Segal RA, Greenberg ME. 1996. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19:463-489.
53. Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. 1992. Lipid composition in different regions of the brain in Alzheimer's disease/ senile dementia of Alzheimer's type. J Neurochem 59:1646-1653.
54. Trapp BD, Nishiyama A, Cheng D, Macklin W. 1997. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137:459-468.
55. Tsai SJ. 2007. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and antiinflammatory effects. Med Hypotheses 69:1219-1221.
56. Van't Veer A, Du Y, Fischer TZ, Boetig DR, Wood MR, Dreyfus CF. 2009. Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway. J Neurosci Res 87:69-78.
57. Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G. 2001. Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol Aging 22:547-553. (Pubitemid 32607738)
58. Ward NL, Hagg T. 2000. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp Neurol 162:297-310.
59. Weinreb O, Amit T, Bar-Am O, Youdim MB. 2007. Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: New insights and implications for therapy. Ann N Y Acad Sci 1122:155-168.
60. Weruaga-Prieto E, Eggli P, Celio MR. 1996. Topographic variations in rat brain oligodendrocyte morphology elucidated by injection of Lucifer Yellow in fixed tissue slices. J Neurocytol 25:19-31.